REVOLUTION Medicines Receives $45,000,000 Series A Financing

  • Feed Type
  • Date
    2/5/2015
  • Company Name
    REVOLUTION Medicines
  • Mailing Address
    Undisclosed Redwood City, CA 94062 USA
  • Company Description
    REVOLUTION Medicines’ first drug candidates exploit and improve upon the properties of amphotericin B, a powerful, broad-spectrum antifungal compound found in nature that has avoided generating significant drug resistance in 50 years of clinical use.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $45,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    With this major advance in chemical synthesis, we now have the opportunity to unlock the full medical benefits of natural products that have been selected through a billion years of evolutionary pressure.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy